Cybin Inc. (NasdaqGM: HELP)
Health Care · Pharmaceuticals · CA
$10.59
+0.76% today · +73.1% 1Y
Cybin Inc. (NasdaqGM: HELP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $767.86M and employs 100 people.
Over the last twelve months the share price has gained 73.1%, trading between 3.76 and 15.15.
Tweenvest scores Cybin Inc. across four factors: quality 36/100, value 83/100. Its strongest factor is value.
HELP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $767.86M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.05
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- $15.15
- 52-week low
- $3.76
- Avg volume (3M)
- —
- Shares outstanding
- 73.06M
- Employees
- 100
- Next earnings
- —
About Cybin Inc.
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
- ISIN
- CA23256X4075
- Listed since
- Sep 13, 2019
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Center Laboratories, Inc.TPEX: 4123 | $774.75M | NT$31.20 | +0.81% |
| Sichuan Goldstone Asia Pharmaceutical Inc.SZSE: 300434 | $773.81M | CN¥12.92 | +4.11% |
| Shanxi Zhendong Pharmaceutical Co.,LtdSZSE: 300158 | $770.73M | CN¥5.21 | +0.58% |
| Shandong Jincheng Pharmaceutical Group Co., LtdSZSE: 300233 | $769.09M | CN¥13.60 | +2.80% |
| Shandong Keyuan Pharmaceutical Co., Ltd.SZSE: 301281 | $762.80M | CN¥47.25 | -4.20% |
| DongKook Pharmaceutical Co., Ltd.KOSDAQ: A086450 | $762.03M | ₩22,750.00 | +6.56% |
| Morepen Laboratories LimitedBSE: 500288 | $760.92M | Rs133.70 | +11.00% |
| Bliss GVS Pharma LimitedBSE: 506197 | $755.62M | Rs684.20 | -3.54% |
Figures last refreshed Oct 4, 2026.